Effect of curcumin on lung resistance-related protein (LRP) in retinoblastoma cells

Current Eye Research

Volumn 34, Issue 10, 2009, Pages 845-851

  Thiyagarajan, Seethalakshmi ^a   Thirumalai, Karthiyayini ^a   Nirmala, Sudarshan ^a   Biswas, Jyotirmay ^a   Krishnakumar, Subramanian ^a  

^a VISION RESEARCH FOUNDATION   (India)

Author keywords

Curcumin; Lung resistance related protein (LRP); Multidrug resistance protein (MDR); Retinoblastoma; Y79

Indexed keywords

BETA ACTIN; CURCUMIN; ETOPOSIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LUNG RESISTANCE PROTEIN; MESSENGER RNA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL DEATH; CELL VIABILITY; CHEMOSENSITIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IC 50; INCUBATION TIME; MODULATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RETINOBLASTOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL LINE, TRANSFORMED; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RETINAL NEOPLASMS; RETINOBLASTOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 70449507309     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713680903125329     Document Type: Article

References (22)

1. Krishnakumar S, Mallikarjuna K, Desai N, Muthialu A, Venkatesan N, Sundaram A, Khetan V, Shanmugam MP. Multidrug resistance proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma. BJO 2004;88:1521-1526.
2. Squire J, Gallie BL, Phillips RA. A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma. Hum Genet 1985;70:291-301.
3. Tan B, Piwnica-Worms D, Ratner L. Multidrug resistance transporters and modulation. Curr Opin Oncol 2000;12:450-458.
4. Lee E, Lim S-J. The association of increased lung resistance protein expression with acquired etoposide resistance in human H460 lung cancer cell lines. Arch Pharm Res 2006;29:1018-1023.
5. Izquierdo MA, Scheffer GL, Flens MJ, Schroeijers AB, Vander Valk P, Scheper RJ. Major vault protein LRP-related multidrug resistance. Euro J Can 1996;32A: 979-984.
6. Kitazono M, Sumizawa T, Takebayashi Y, Chen Z-S, Furukawa T, Nagayama S, Tani A, Takao S, Aikou T, Akiyama S-I. Multidrug resistance and the lung resistancerelated protein in human colon carcinoma SW-620 cells. J Natl Cancer Inst 1999;91:1647-1653.
7. Mossink MH, van Zon A, Scheper RJ, Sonnevel P, Wiemer EAC. Vaults: A ribonuclear protein particle involved in multidrug resistance? Oncogene 2003;22:7458-7467.
8. Yanagisawa T. Systemic chemotherapy as a new conservative treatment for intraocular retinoblastoma. Int J Clin Onco 2004;9:13-24.
9. Eckstein LA, Van Quill KR, Bui SK, Uusitalo MS, O'Brien JM. Cyclosporin A inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells. IOVS 2005;46:782-790.
10. Chearwae W, Anuchapreeda S, Nandigama K, Ambudkar SV, Limtrakul P. Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from turmeric powder. Biochem Pharm 2004;68:2043-2052.
11. Anuchapreeda S, Leechanachai P, Smith MM, Ambudhkar SV, Limtrakul P. Modulation of P-glycoprotein expression and function by curcumin in multidrug resistance human KB cells. Biochem Pharm 2002; 64:573-582.
12. Limtrakul P, Anuchapreeda S, Buddhasukh D. Modulation of human multidrug resistance MDR1 gene by natural curcuminoids. BMC Cancer 2004;13:1-6.
13. Li M, Zhang Z, Hill DL, Wang H, Zhang R. Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway. Can Res 2007;67:1988-1996.
14. Waiwut P, Anuchapreeda S, Limtrakul P-N. Curcumin inhibits P-glycoprotein level in the caricinoma of cervix cells (KB-carcinoma cell lines) induced by vinblastine. Chiang Mai Med Bull 2002;41:139-145.
15. Tang X-Q, BI H, Feng J-Q, Cao J-G. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR. Acta Pharma Sinica 2005;26:1009-1016.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-275.
17. Bharat BA, Kumar A, Aggarwal MS, Shishodia S. Phytopharmaceuticals in cancer chemoprevention. Curcumin derived from Turmeric (Curcumo longa): A spice for all seasons. Phytopharmaceuticals in Cancer Chemoprevention 2005; 349-387.
18. Chearwae W, Wu C-P, Chu Hr, Lee TR, Ambudkar SV, Limtrakul P. Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1). Cancer Chemo Pharma 2006;57:376-388.
19. Beevers CS, Li F, Liu L, Huang S. Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells. Int J Can 2006;119:757-764.
20. Syng-ai C, Kumari AL, Khar A. Effect of curcumin on normal and tumor cells: Role of glutathione and bcl-2. Molec Cancer Therapeut 2004;3:1101-1108.
21. Chearwae W, Shukla S, Limtrakul P, Ambudhkar SV. Modulation of the function of the multidrug resistancelinked ATP-binding cassette transporter ABCG2 by the cancer chemopreventive agent curcumin. Mol Cancer Ther 2006;5:1995-2006.
22. Steiner E, Holzmann K, Pircker C, Elbling L, Micksche M, Sutterluty H, Berger W. The major vault protein is responsive to and interferes with interferon-g-mediated STAT1 signals. J Cell Sci 2006;119:459-469.